Documents

A list of downloadable documents created during development.

Expected publication

Final appraisal determination

Appraisal consultation: 1

Assessment report

Final scope

Final matrix

Comments table

Colorectal cancer (metastatic) - cetuximab (review TA176) and panitumumab (part review TA240) (1st line): final protocol

Colorectal cancer (metastatic) - cetuximab (review TA176) and panitumumab (part review TA240) (1st line): equality impact assessment scoping

Colorectal cancer (metastatic) - cetuximab (review TA176) and panitumumab (part review TA240) (1st line): provisional matrix

Colorectal cancer (metastatic) - cetuximab (review TA176) and panitumumab (part review TA240) (1st line): draft scope